Anna-Marie Fairhurst Selected Research

Antibodies

2/2017

Clinical utility of circulating anti-N-methyl-d-aspartate receptor subunits NR2A/B antibody for the diagnosis of neuropsychiatric syndromes in systemic lupus erythematosus and Sjögren's syndrome: An updated meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna-Marie Fairhurst Research Topics

Disease

6	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2018 - 01/2006
5	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 01/2006
4	Splenomegaly 11/2021 - 04/2009
4	Inflammation (Inflammations) 10/2020 - 12/2012
3	Human Influenza (Influenza) 01/2020 - 01/2013
3	Infections 01/2020 - 01/2019
3	Lupus Nephritis 08/2019 - 11/2015
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Kidney Diseases (Kidney Disease) 11/2021 - 12/2012
2	Glomerulonephritis 01/2019 - 11/2009
2	Nephritis 11/2015 - 11/2009
1	Cytokine Release Syndrome 01/2022
1	Fever (Fevers) 01/2022
1	Starvation 01/2020
1	Myocardial Infarction 10/2019
1	Cicatrix (Scar) 10/2019
1	Heart Rupture 10/2019
1	Chronic Renal Insufficiency 01/2019
1	Breast Neoplasms (Breast Cancer) 12/2017
1	Mood Disorders (Mood Disorder) 02/2017
1	Cognitive Dysfunction 02/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2017
1	Necrosis 06/2007
1	Rheumatoid Arthritis 01/2007
1	Arthritis (Polyarthritis) 01/2003
1	Septic Shock (Toxic Shock Syndrome) 01/2003
1	Communicable Diseases (Infectious Diseases) 01/2003

Drug/Important Bio-Agent (IBA)

7	AutoantibodiesIBA 11/2021 - 01/2006
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2017
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	RNA (Ribonucleic Acid)IBA 01/2020 - 12/2012
2	Interferon Type IIBA 10/2020 - 11/2009
2	Annexin A1IBA 01/2020 - 12/2017
2	Toll-Like Receptor 7IBA 10/2019 - 11/2015
2	Antinuclear AntibodiesIBA 01/2019 - 12/2012
2	VaccinesIBA 12/2018 - 01/2013
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2018 - 01/2014
2	Antigen-Antibody Complex (Immune Complex)IBA 10/2018 - 01/2007
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	CRISPR-Associated Protein 9IBA 01/2020
1	5'PPP-RNAIBA 01/2020
1	Sirolimus (Rapamycin)FDA Link 01/2020
1	CalciumIBA 01/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020
1	MTOR InhibitorsIBA 01/2020
1	Tissue Inhibitor of Metalloproteinase-1IBA 10/2019
1	CollagenIBA 10/2019
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2019
1	ChromatinIBA 01/2019
1	Fibrinolysin FDA Link 01/2019
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2019
1	Thromboplastin (Tissue Factor)IBA 01/2019
1	fibrin fragment D (D-dimer)IBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 12/2018
1	Interleukin-10 (Interleukin 10)IBA 12/2018
1	Interleukin-5 (Interleukin 5)IBA 12/2018
1	interleukin-21 (interleukin 21)IBA 12/2018
1	CytokinesIBA 12/2018
1	Interleukin-13IBA 12/2018
1	Interleukin-9 (Interleukin 9)IBA 12/2018
1	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2018
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2017
1	AntibodiesIBA 02/2017
1	Sialic Acid Binding Immunoglobulin-like LectinsIBA 01/2017
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2014
1	antineoplaston A10 (A 10)IBA 01/2013
1	Neutralizing AntibodiesIBA 01/2013
1	aluminum sulfate (alum)IBA 01/2013
1	panvaxIBA 01/2013
1	Peptides (Polypeptides)IBA 04/2009
1	DNA (Deoxyribonucleic Acid)IBA 06/2007
1	Immunoglobulin G (IgG)IBA 01/2007
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2003

Therapy/Procedure

2	Immunotherapy 01/2022 - 01/2019
1	Therapeutics 01/2017